ABVC BioPharma, Inc. logo

ABVC BioPharma, Inc. (ABVC) Q1 2025 Annual Earnings

ABVC·Reported April 30, 2025·Before market open

Diluted EPS came in at $-0.06.

Diluted EPS
$-0.06
SEC

SEC Filings

Earnings release8-K not filed yet
Annual report10-K · 0001213900-25-032118

Financial Snapshot

Trailing eight quarters through Q1 2025

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q1 2025 Earnings FAQ

Common questions about ABVC BioPharma, Inc.'s Q1 2025 earnings report.

ABVC BioPharma, Inc. (ABVC) reported Q1 2025 earnings on April 30, 2025 before market open.

ABVC BioPharma, Inc. reported diluted EPS of $-0.06 for Q1 2025.

You can read the 10-K periodic report (0001213900-25-032118) directly on SEC EDGAR. The filing index links above go to sec.gov.